| Field | Specification |
|---|---|
| Mfr No | |
| Activity | |
| Alternative Names | 4-(3-(Methylsulfonyl)phenyl)-1-propylpiperidine; ACR16 |
| Cas No. | |
| Form | White powder |
| Molecular Weight | |
| Product Type | |
| Purity | |
| Shipping | |
| SMILES | |
| Solubility | May be dissolved in DMSO (10 mg/ml) |
| Source | Synthetic |
| Storage |
Pridopidine is a small molecule with neuroprotective potential, primarily investigated for Huntington’s disease, Parkinson’s disease, and schizophrenia. Initially described as a dopamine stabilizer due to its ability to modulate dopaminergic tone without inducing catalepsy, its mechanism is now attributed to high-affinity binding at the sigma-1 receptor. This receptor is implicated in cellular stress responses, neuroprotection, and synaptic plasticity. Pridopidine has demonstrated the ability to restore neuronal function, enhance neurotrophic signaling, and reduce neurodegeneration in preclinical models. Its sigma-1-mediated effects also extend to models of amyotrophic lateral sclerosis (ALS), highlighting its broad therapeutic potential in neurodegenerative disease research.
Classification: Warning
GHS Hazard Statements:
H302, H361d
Precautionary Statement Codes:
P203, P264, P270, P280, P301+P317, P318, P330, P405, and P501
Pridopidine (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-626)
Need this compound in a format that drops straight into your assay? We can tailor formulation, chemistry, and documentation so your results stay consistent across runs and re-orders.
- Format options: solid or pre-dissolved solution (choose solvent), target concentration, aliquots, light/moisture-protected packaging
- Chemistry options: free base/acid vs salt forms, hydrate/solvate preference, stereoisomer control (single enantiomer or racemate), close analogs
- Add-on labels & handles: D/¹³C/¹⁵N isotopes (LC-MS/internal standards), azide/alkyne or other functional handles for conjugation
- QC & documentation: standard COA or enhanced analytical pack (HPLC/LC-MS/NMR), chiral purity, residual solvents, water content (KF), method-specific specs
- Scale & continuity: mg to gram scale, bulk pricing, lot reservation, repeat-order continuity
To quote quickly, tell us: compound name + CAS/structure (SMILES or mol file), intended assay context, solvent preference, salt/stereochemistry requirements, purity/QC level, and the amount (mg–g).
Can’t find the compound you’re looking for?
Send the CAS or structure and your specs. We can help source it, suggest close
equivalents, or discuss custom synthesis with the right QC documentation (RUO).
2. S Natesan et al. 2006 J. Pharmacol. Exp. Ther. 318:810.
3. T Dyhring et al. 2010 Eur. J. Pharmacol. 628:19.
4. K Sahlholm et al. 2015 Psychopharmacology (Berl) 232:3443.
5. K Sahlholm et al. 2013 Mol. Psychiatry 18:12.
6. V Francardo et al. 2019 Neurotherapeutics 16:465.
7. D Ryskamp et al. 2017 Neurobiol. Dis. 7 97(Pt A):46.
8. A Ionescu et al. 2019 Cell Death Dis. 10:210.